Fig. 1From: Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart reviewOverall Survival Curve for Grade 1, 2, and 3 Meningiomas Treated with RT and Concomitant TMZ after Initial Surgical Resection. Three of eleven patients died during the follow-up period; one being disease related at 2.3Â months with a WHO Grade 3 meningiomaBack to article page